» Articles » PMID: 8196770

Ras-dependent Activation of MAP Kinase Pathway Mediated by G-protein Beta Gamma Subunits

Overview
Journal Nature
Specialty Science
Date 1994 Jun 2
PMID 8196770
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen-activated protein kinases, MAP kinases or ERKs (extracellular signal-regulated kinases) are rapidly stimulated by growth-promoting factors acting on a variety of cell-surface receptors. In turn, ERKs phosphorylate and regulate key intracellular enzymes and transcription factors involved in the control of cellular proliferation. The tyrosine-kinase class of growth-factor receptors transmits signals to ERKs in a multistep process that involves Ras and a limited number of defined molecules. In contrast, ERK activation by G-protein-coupled receptors is poorly understood, as is the role of ras in this signalling pathway. We have explored in COS-7 cells the mechanism of ERKs activation by m1 and m2 muscarinic receptors, typical examples of receptors coupled through Gq proteins to induce phosphatidylinositol hydrolysis and to G(i) proteins to inhibit adenylyl cyclase, respectively. Here we present evidence that ERK activation is mediated by beta gamma subunits of heterotrimeric G proteins acting on a ras-dependent pathway.

Citing Articles

A molecular mechanism to diversify Ca signaling downstream of Gs protein-coupled receptors.

Brands J, Bravo S, Jurgenliemke L, Gratz L, Schihada H, Frechen F Nat Commun. 2024; 15(1):7684.

PMID: 39227390 PMC: 11372221. DOI: 10.1038/s41467-024-51991-6.


Engagement of -methyladenisine methylation of mRNA in astrocyte dysfunction regulated by CircHECW2.

Bai Y, Chang D, Ren H, Ju M, Wang Y, Chen B Acta Pharm Sin B. 2024; 14(4):1644-1660.

PMID: 38572093 PMC: 10985031. DOI: 10.1016/j.apsb.2024.01.011.


Molecular basis of opioid receptor signaling.

Che T, Roth B Cell. 2023; 186(24):5203-5219.

PMID: 37995655 PMC: 10710086. DOI: 10.1016/j.cell.2023.10.029.


New insights into RAS in head and neck cancer.

Jagadeeshan S, Novoplansky O, Cohen O, Kurth I, Hess J, Rosenberg A Biochim Biophys Acta Rev Cancer. 2023; 1878(6):188963.

PMID: 37619805 PMC: 11815531. DOI: 10.1016/j.bbcan.2023.188963.


The olfactory receptor OR51E2 activates ERK1/2 through the Golgi-localized Gβγ-PI3Kγ-ARF1 pathway in prostate cancer cells.

Xu X, Khater M, Wu G Front Pharmacol. 2022; 13:1009380.

PMID: 36313302 PMC: 9606680. DOI: 10.3389/fphar.2022.1009380.